Literature DB >> 7829013

Digestibility and bulking effect of ispaghula husks in healthy humans.

P Marteau1, B Flourié, C Cherbut, J L Corrèze, P Pellier, J Seylaz, J C Rambaud.   

Abstract

The digestibility of ispaghula, a mucilage from Plantago ovata composed mainly of arabinoxylans, and its faecal bulking effect were studied in seven healthy volunteers who ingested a low fibre controlled diet plus either placebo or 18 g/day of ispaghula for two 15 day periods. Whole gut transit time and gas excretion in breath and flatus were not different during the periods of ispaghula and placebo ingestion. Faecal wet and dry weights rose significantly, however, during ispaghula ingestion. Faecal short chain fatty acid concentrations and the molar proportions of propionic and acetic acids also increased. Most of the ispaghula had reached the caecum four hours after ingestion in an intact highly polymerised form. During ispaghula ingestion, the increase in the faecal output of neutral sugars was accounted for by the faecal excretion of arabinose and xylose in an intact highly polymerised form; the apparent digestibilities of these sugars were 24 (11) and 53% (6) respectively (mean (SEM)). In conclusion, ispaghula is more resistant to fermentation than previously reported in humans, and its bulking effect largely results from intact material.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7829013      PMCID: PMC1375264          DOI: 10.1136/gut.35.12.1747

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  31 in total

1.  Which fibre is best for the colon?

Authors:  J Tomlin
Journal:  Scand J Gastroenterol Suppl       Date:  1987

2.  Dietary fibre fermentation in the rat intestinal tract: effect of adaptation period, protein and fibre levels, and particle size.

Authors:  M Nyman; N G Asp
Journal:  Br J Nutr       Date:  1985-11       Impact factor: 3.718

3.  Double blind study of ispaghula in irritable bowel syndrome.

Authors:  A Prior; P J Whorwell
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

4.  Decomposition of wheat bran and ispaghula husk in the stomach and the small intestine of healthy men.

Authors:  J R Andersen; K Bukhave; L Højgaard; H S Rasmussen; N Hermansen; H Worning; E Krag
Journal:  J Nutr       Date:  1988-03       Impact factor: 4.798

5.  The influence of ispaghula husk and lactulose on the in vivo and the in vitro production capacity of short-chain fatty acids in humans.

Authors:  H S Rasmussen; K Holtug; J R Andersen; E Krag; P B Mortensen
Journal:  Scand J Gastroenterol       Date:  1987-05       Impact factor: 2.423

6.  Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: correlation of symptom relief with whole gut transit time and stool weight.

Authors:  A Kumar; N Kumar; J C Vij; S K Sarin; B S Anand
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

7.  Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study).

Authors:  C Florent; B Flourie; A Leblond; M Rautureau; J J Bernier; J C Rambaud
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

8.  Circulating tachykinins (substance P, neurokinin A, neuropeptide K) and the carcinoid flush.

Authors:  J M Conlon; C F Deacon; G Richter; F Stöckmann; W Creutzfeldt
Journal:  Scand J Gastroenterol       Date:  1987-01       Impact factor: 2.423

9.  Comparison of the effects of psyllium and wheat bran on gastrointestinal transit time and stool characteristics.

Authors:  J Stevens; P J VanSoest; J B Robertson; D A Levitsky
Journal:  J Am Diet Assoc       Date:  1988-03

10.  Bulk laxatives: their dietary fibre composition, degradation, and faecal bulking capacity in the rat.

Authors:  M Nyman; N G Asp
Journal:  Scand J Gastroenterol       Date:  1985-09       Impact factor: 2.423

View more
  15 in total

1.  Comparative study of bacterial groups within the human cecal and fecal microbiota.

Authors:  P Marteau; P Pochart; J Doré; C Béra-Maillet; A Bernalier; G Corthier
Journal:  Appl Environ Microbiol       Date:  2001-10       Impact factor: 4.792

Review 2.  Intestinal microflora as a therapeutic target in inflammatory bowel disease.

Authors:  Keiichi Mitsuyama; Atsushi Toyonaga; Michio Sata
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

3.  Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?

Authors:  P Marteau
Journal:  Gut       Date:  2006-12       Impact factor: 23.059

4.  Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial.

Authors:  Heather E Rasmussen; Bruce Hamaker; Kumar B Rajan; Ece Mutlu; Stefan J Green; Michael Brown; Amandeep Kaur; Ali Keshavarzian
Journal:  Nutr Res       Date:  2017-06-02       Impact factor: 3.315

5.  Psyllium Fiber Reduces Abdominal Pain in Children With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial.

Authors:  Robert J Shulman; Emily B Hollister; Kevin Cain; Danita I Czyzewski; Mariella M Self; Erica M Weidler; Sridevi Devaraj; Ruth Ann Luna; James Versalovic; Margaret Heitkemper
Journal:  Clin Gastroenterol Hepatol       Date:  2016-04-11       Impact factor: 11.382

6.  Usefulness of psyllium in rehabilitation of obstructed defecation.

Authors:  F Pucciani; M Raggioli; M N Ringressi
Journal:  Tech Coloproctol       Date:  2011-07-22       Impact factor: 3.781

7.  Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA.

Authors:  Hans G H J Heilig; Erwin G Zoetendal; Elaine E Vaughan; Philippe Marteau; Antoon D L Akkermans; Willem M de Vos
Journal:  Appl Environ Microbiol       Date:  2002-01       Impact factor: 4.792

8.  Inhibitory actions of a high fibre diet on intestinal gas transit in healthy volunteers.

Authors:  S Gonlachanvit; R Coleski; C Owyang; Wl Hasler
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

9.  Partially hydrolyzed guar gum in pediatric functional abdominal pain.

Authors:  Claudio Romano; Donatella Comito; Annalisa Famiani; Sabrina Calamarà; Italia Loddo
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

10.  Evidence-Based Approach to Fiber Supplements and Clinically Meaningful Health Benefits, Part 2: What to Look for and How to Recommend an Effective Fiber Therapy.

Authors:  Johnson W McRorie
Journal:  Nutr Today       Date:  2015-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.